Company Update: SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM | Learn More
Logo yposkesi
waves image

Meet our team at the World Oncology Cell Therapy Congress US: April 25-26, 2023 in Boston, MA.

The event

The World Oncology Cell Therapy Congress US will take place April 25-26 2023 at the Hyatt Regency in Boston, MA.

Learn more about the event

Our team

Our team

Meet our team during the event: 

Stop by our booth #17 to meet our team during the World Oncology Cell Therapy Congress US and learn more about our extended services to bring your cell and gene therapies to life… From process development up to commercial launch, Yposkesi is the full-service CDMO of choice, working by your side, to meet your timelines and budget.

Learn more about our newly launched Lentiviral Vector Manufacturing Platform: LentiSure!

At the beginning of April 2023, Yposkesi launched its new Lentiviral Vector Manufacturing Platform, LentiSure.

LentiSure is providing the premium quality grade lentiviral vectors you need to assure your clinical development and commercial cell and gene therapy pipeline. LentiSure’s robust, scalable, and plug & play-optimized processes enable you to accelerate the time to market of your cell and gene therapies and facilitate better patient outcomes. You obtain a safe and effective product through LentiSure’s high productivity and established analytical methods. LentiSure is the choice for high titers, transduction efficiency, reliability, and accessing scalable production processes with optimized purification techniques.


Learn more about LentiSure
Created by Yerokhoff Kostyiantine